title: GPIIb/IIIa Receptor Antagonism Using Small Molecules Provides no Additive Long-Term Protection after Percutaneous Coronary Intervention as Compared to Clopidogrel Plus Aspirin.
authors.affiliation: S. Anna Hospital, Catanzaro University "La Sapienza", Rome, Italy.
authors.forename: Michele
authors.initials: M
authors.lastname: Schiariti
authors.forename: Angela
authors.initials: A
authors.lastname: Saladini
authors.forename: Francesco
authors.initials: F
authors.lastname: Papalia
authors.forename: Placido
authors.initials: P
authors.lastname: Grillo
authors.forename: Cristina
authors.initials: C
authors.lastname: Nesta
authors.forename: Domenico
authors.initials: D
authors.lastname: Cuturello
authors.forename: Bindo
authors.initials: B
authors.lastname: Missiroli
authors.forename: Paolo Emilio
authors.initials: PE
authors.lastname: Puddu